Recent Highlights Revenue was $134.3 million for the first quarter, representing a 17% increase over the corresponding period of 2022. Surpassed 5,000 ...
Rakovina Therapeutics also announced that it will issue approximately thirty (30) unsecured $50,000 convertible debenture units to a select group of i...
Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, ...
The items on the agenda of the ordinary and extraordinary general shareholders' meetings include the proposed approval of a number of resolutions relating ...
Recorded Q1'23 consolidated revenue of KRW 720.9 billion. Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. Expected to main...
Revenue Up 5.8% Year-Over-Year to RMB8,964 MillionNet Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 MillionDiluted ...
Adcentrx Therapeutics ("Adcentrx"), a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other li...
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposa...
Aptitude Medical Systems (Aptitude™) announced today that it has received an award up to $53.7 million from Biomedical Advanced Research and Developm...
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its res...
Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, a...
Nicox’s partner, Ocumension Therapeutics, submits a New Drug Application for ZERVIATE in China ZERVIATE® approval and launch expected ...
To participate, call 833-470-1428 within the U.S. or +1 929-526-1599 outside the U.S., access code: 522530. A live webcast of the conference call will also...
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and advancement of Araris’ antibody-drug conjugat...
© 2025 Biopharma Boardroom. All Rights Reserved.
